<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02558699</url>
  </required_header>
  <id_info>
    <org_study_id>4-2015-0646</org_study_id>
    <nct_id>NCT02558699</nct_id>
  </id_info>
  <brief_title>Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Virtual Rotor Mapping and Catheter Ablation</brief_title>
  <acronym>CUVIA-AF II</acronym>
  <official_title>Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Virtual Rotor Mapping and Catheter Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Radiofrequency catheter ablation is effective in the treatment of patients with paroxysmal
      atrial fibrillation. In order to reduce the recurrence rate after catheter ablation, we
      propose to apply 'virtual' ablation on patient-specific atria by simulating 3D atrial
      computer model. We will conduct virtual rotor mapping in the patient specific atrial model.
      Then, we will compare the clinical outcome of conventional circumferential pulmonary vein
      isolation and additional rotor ablation guided by virtual rotor mapping.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2019</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recurrence rate of atrial fibrillation</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>rate of hospitalization</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>incidence of ischemic cerebral infarction</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major complication of hemorrhagic and embolic</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>conventional group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group operating the atrial fibrillation by physician's personal experience, not by virtual simulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3D atrial computer model</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group choosing choose the best effective rotor mapping by simulating 3D atrial computer model which consider patinet's heart size and shape.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>physician's personal experience</intervention_name>
    <description>physician's personal experience</description>
    <arm_group_label>conventional group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Virtual rotor mapping</intervention_name>
    <description>Virtual rotor mapping</description>
    <arm_group_label>3D atrial computer model</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AF patient age 19~80

          -  Diagnosis of AF patients who performed catheter ablation of atrial fibrillation due to
             uncontrolled pulse rate by anti-arrhythmic drug therapy.

        Exclusion Criteria:

          -  AF patients who have severe heart deformations or vascular disease.

          -  The patient who have renal disease of eGFR&lt;30mL/min

          -  The patients who had been performed catheter ablation of atrial ablation and MAZE.

          -  The patients who missed out to recording of 3D CT, echo and electrocardiography.

          -  the patient have experienced major hemorrhagic complication

          -  The patient have experienced ischemic cerebral infarction more 2 times

          -  The patient who have risk of ischemic cerebral infarction (CHA2DS2-VASc Score &gt;5)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Severance Cardiovascular Hospital, Yonsei University Health System</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Hui-Nam Pak, M.D., Ph.D.</last_name>
      <phone>82-2-2228-8459</phone>
      <email>hnpak@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>September 23, 2015</study_first_submitted>
  <study_first_submitted_qc>September 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2015</study_first_posted>
  <last_update_submitted>February 11, 2019</last_update_submitted>
  <last_update_submitted_qc>February 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

